7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 
      
                          
      assets
                          
      current assets:
                          
      cash and cash equivalents
    547,194,000 481,537,000 222,353,000 224,680,000 218,426,000 200,858,000 224,497,000 243,576,000 227,619,000 211,471,000 200,340,000 224,338,000 225,480,000 182,349,000 164,595,000 177,150,000 227,148,000 226,485,000 196,190,000 194,868,000 177,457,000 38,424,000 
      trade accounts receivable, net of allowances of 528 and 577 at september 30, 2025 and december 31, 2024, respectively
    154,680,000                      
      deferred contract costs
    29,344,000 29,485,000 28,513,000 27,958,000 26,643,000 25,727,000 24,514,000 23,508,000 21,693,000 20,386,000 18,780,000 17,652,000 16,472,000 15,460,000 14,142,000 12,904,000 11,673,000 10,480,000 11,155,000 9,959,000 8,528,000 7,270,000 
      prepaid expenses
    24,688,000 22,017,000 23,121,000 12,679,000 18,861,000 18,518,000 21,314,000 14,255,000 15,938,000 18,092,000 22,903,000 14,331,000 16,186,000 17,513,000 19,616,000 17,581,000 18,677,000 14,432,000 15,009,000 13,283,000 16,565,000 10,880,000 
      other current assets
    21,306,000 18,901,000 19,179,000 20,549,000 20,787,000 19,823,000 20,913,000 13,055,000 10,733,000 8,078,000 6,535,000 6,097,000 6,224,000 4,953,000 4,318,000 4,212,000 3,592,000 2,687,000 2,325,000 1,113,000 764,000 6,314,000 
      total current assets
    777,212,000 702,266,000 431,582,000 424,657,000 398,735,000 373,999,000 386,722,000 402,634,000 372,022,000 358,993,000 333,756,000 351,046,000 357,650,000 317,175,000 284,079,000 291,598,000 331,228,000 321,316,000 301,193,000 288,911,000 268,137,000 116,717,000 
      equipment and leasehold improvements
    17,929,000 18,838,000 20,711,000 19,321,000 18,773,000 14,264,000 14,858,000 15,184,000 16,400,000 17,514,000 18,615,000 19,421,000 19,116,000 17,334,000 18,237,000 18,045,000 17,529,000 17,223,000 16,965,000 12,755,000 10,934,000 11,494,000 
      goodwill
    1,057,686,000 1,063,111,000 891,050,000 882,593,000 900,092,000 885,404,000 885,041,000 887,121,000 876,822,000 867,909,000 862,747,000 856,925,000 800,524,000 823,671,000 841,984,000 845,734,000 846,057,000 541,850,000 541,850,000 541,480,000 539,818,000 539,818,000 
      other intangible assets
    186,125,000 200,324,000 139,446,000 147,823,000 160,505,000 167,779,000 177,253,000 187,891,000 196,514,000 200,128,000 209,509,000 218,744,000 215,064,000 233,557,000 251,072,000 264,593,000 276,750,000 189,021,000 197,504,000 202,878,000 210,120,000 218,430,000 
      deferred contract costs, non-current
    57,420,000 59,410,000 59,061,000 59,663,000 56,679,000 55,897,000 54,040,000 53,070,000 48,871,000 46,145,000 41,933,000 39,643,000 36,960,000 34,823,000 31,793,000 29,842,000 27,830,000 25,993,000     
      other assets
    42,801,000 45,922,000 46,782,000 46,172,000 49,426,000 49,398,000 45,838,000 43,752,000 41,423,000 42,340,000 42,409,000 43,763,000 38,128,000 39,530,000 39,159,000 30,608,000 30,685,000 28,112,000 28,898,000 5,359,000 2,842,000 2,557,000 
      total assets
    2,139,173,000 2,089,871,000 1,588,632,000 1,580,229,000 1,584,210,000 1,546,741,000 1,563,752,000 1,589,652,000 1,552,052,000 1,533,029,000 1,508,969,000 1,529,542,000 1,467,442,000 1,466,090,000 1,466,324,000 1,480,420,000 1,530,079,000 1,123,515,000 1,115,184,000 1,078,153,000 1,055,284,000 909,350,000 
      liabilities and stockholders’ equity
                          
      current liabilities:
                          
      accounts payable
    20,461,000 16,566,000 20,273,000 18,405,000 21,965,000 18,901,000 20,388,000 25,909,000 21,070,000 15,168,000 14,982,000 15,393,000 16,870,000 9,506,000 8,808,000 9,306,000 12,717,000 9,037,000 5,744,000 6,967,000 6,672,000 3,909,000 
      accrued liabilities
    101,375,000 96,727,000 51,661,000 68,363,000 69,526,000 73,782,000 70,533,000 77,447,000 68,088,000 56,902,000 48,993,000 67,051,000 57,351,000 50,761,000 45,558,000 54,022,000 98,598,000 38,263,000 28,131,000 31,574,000 21,521,000 26,099,000 
      income taxes payable
    374,000 3,556,000 119,000 1,014,000 1,430,000 1,467,000 1,346,000 1,248,000 1,018,000 866,000 547,000 486,000 752,000 203,000 376,000 167,000 730,000 417,000 1,153,000 713,000 1,294,000 1,081,000 
      deferred revenue
    380,186,000 350,942,000 327,009,000 333,573,000 326,107,000 314,893,000 311,698,000 317,546,000 311,138,000              
      convertible senior notes, net, current
    371,413,000                      
      term loan, net, current
    20,000,000 15,000,000                     
      total current liabilities
    893,809,000 482,791,000 399,062,000 421,355,000 419,028,000 409,043,000 403,965,000 422,150,000 401,314,000 363,599,000 342,929,000 360,968,000 346,694,000 309,844,000 289,131,000 286,526,000 323,074,000 228,424,000 202,896,000 199,697,000 181,019,000 161,398,000 
      deferred revenue, non-current
    60,308,000 57,248,000 52,085,000 52,136,000 52,110,000 55,313,000 52,805,000 55,886,000 58,616,000              
      deferred tax liability
    4,804,000 4,836,000 5,132,000 5,180,000 5,327,000 5,021,000 5,515,000 5,952,000 5,624,000 5,146,000 5,539,000 5,505,000 5,418,000 7,596,000 8,097,000 8,700,000 11,455,000 4,306,000 5,475,000 6,422,000 12,774,000 14,913,000 
      convertible senior notes, net, non-current
                          
      term loan, net, non-current
    377,841,000 382,691,000                     
      other liabilities
    15,693,000 16,362,000 14,985,000 16,061,000 18,333,000 16,866,000 17,771,000 21,118,000 20,707,000 25,783,000 27,480,000 29,114,000 22,173,000 23,861,000 26,417,000 25,640,000 27,969,000 29,076,000 33,839,000 11,046,000 9,399,000 6,876,000 
      total liabilities
    1,352,455,000 1,314,707,000 841,410,000 864,246,000 863,681,000 854,491,000 847,682,000 872,105,000 852,635,000 824,666,000 803,510,000 828,204,000 807,679,000 772,144,000 744,403,000 741,994,000 783,310,000 319,556,000 295,921,000 262,672,000 239,898,000 412,507,000 
      commitments and contingencies
                          
      stockholders’ equity:
                          
      preferred stock, 0.001 par value, 50,000,000 shares authorized at september 30, 2025 and december 31, 2024; no shares issued and outstanding at september 30, 2025 and december 31, 2024
                          
      common stock
    125,000 125,000 125,000 125,000 125,000 124,000 126,000 126,000 126,000 125,000 124,000 123,000 120,000 120,000 119,000 119,000 119,000 118,000 118,000 117,000 117,000 103,000 
      treasury stock
       -741,000                   
      additional paid-in capital
    1,346,005,000 1,323,383,000 1,292,918,000                    
      accumulated other comprehensive loss
    -11,948,000 -5,393,000 -23,745,000 -30,060,000 -15,135,000 -28,278,000 -28,589,000 -26,777,000 -36,051,000 -28,357,000 -33,904,000 -39,951,000 -64,084,000 -37,574,000 -15,949,000 -7,866,000 -8,120,000      
      accumulated deficit
    -547,464,000 -542,951,000 -522,076,000 -522,605,000 -506,177,000 -493,936,000 -439,319,000 -418,795,000 -401,385,000 -369,108,000 -332,909,000 -308,709,000 -287,478,000 -256,176,000 -193,037,000 -167,408,000 -143,658,000 -113,275,000 -90,821,000 -87,752,000 -78,787,000 -73,694,000 
      total stockholders’ equity
    786,718,000 775,164,000 747,222,000 715,983,000 720,529,000 692,250,000 716,070,000 717,547,000 699,417,000 708,363,000 705,459,000 701,338,000 659,763,000 693,946,000 721,921,000 738,426,000 746,769,000 803,959,000 819,263,000 815,481,000 815,386,000 496,843,000 
      total liabilities and stockholders’ equity
    2,139,173,000 2,089,871,000 1,588,632,000 1,580,229,000 1,584,210,000 1,546,741,000 1,563,752,000 1,589,652,000 1,552,052,000 1,533,029,000 1,508,969,000 1,529,542,000 1,467,442,000 1,466,090,000 1,466,324,000 1,480,420,000 1,530,079,000 1,123,515,000 1,115,184,000 1,078,153,000 1,055,284,000 909,350,000 
      trade accounts receivable, net of allowances of 591 and 577 at june 30, 2025 and december 31, 2024, respectively
     150,326,000                     
      convertible senior notes
     370,779,000 370,146,000 369,514,000 368,883,000 368,248,000 367,626,000 366,999,000 366,374,000 365,750,000 365,127,000 364,505,000 363,885,000 363,265,000 362,648,000 362,031,000 361,474,000      
      preferred stock, 0.001 par value, 50,000,000 shares authorized at june 30, 2025 and december 31, 2024; no shares issued and outstanding at june 30, 2025 and december 31, 2024
                          
      trade accounts receivable, net of allowances of 475 and 577 at march 31, 2025 and december 31, 2024, respectively
      138,416,000                    
      preferred stock, 0.001 par value, 50,000,000 shares authorized at march 31, 2025 and december 31, 2024; no shares issued and outstanding at march 31, 2025 and december 31, 2024
                          
      trade accounts receivable, net of allowances of 577 and 444 at december 31, 2024 and 2023, respectively
       138,791,000                   
      preferred stock, 0.001 par value, 50,000,000 shares authorized at december 31, 2024 and 2023; no shares issued and outstanding at december 31, 2024 and 2023
                          
      additional paid‑in capital
       1,269,264,000 1,241,716,000 1,214,340,000 1,183,852,000 1,162,993,000 1,136,727,000 1,105,703,000 1,072,148,000 1,049,875,000 1,011,205,000 987,576,000 930,788,000 913,581,000 898,428,000 917,116,000 909,966,000 903,116,000 894,056,000 570,434,000 
      trade accounts receivable, net of allowances of 460 and 444 at september 30, 2024 and december 31, 2023, respectively
        114,018,000                  
      preferred stock, 0.001 par value, 50,000,000 shares authorized at september 30, 2024 and december 31, 2023; no shares issued and outstanding at september 30, 2024 and december 31, 2023
                          
      trade accounts receivable, net of allowances of 442 and 444 at june 30, 2024 and december 31, 2023, respectively
         109,073,000                 
      preferred stock, 0.001 par value, 50,000,000 shares authorized at june 30, 2024 and december 31, 2023; no shares issued and outstanding at june 30, 2024 and december 31, 2023
                          
      trade accounts receivable, net of allowances of 387 and 444 at march 31, 2024 and december 31, 2023, respectively
          95,484,000                
      preferred stock, 0.001 par value, 50,000,000 shares authorized at march 31, 2024 and december 31, 2023; no shares issued and outstanding at march 31, 2024 and december 31, 2023
                          
      trade accounts receivable, net of allowances of 444 and 445 at december 31, 2023 and 2022, respectively
           108,240,000               
      preferred stock, 0.001 par value, 50,000,000 shares authorized at december 31, 2023 and 2022; no shares issued and outstanding at december 31, 2023 and 2022
                          
      trade accounts receivable, net of allowances of 484 and 445 at september 30, 2023 and december 31, 2022, respectively
            95,361,000              
      income taxes receivable
            678,000 782,000 806,000 465,000 406,000 450,000 287,000 608,000 652,000 565,000 632,000 632,000 672,000 554,000 
      preferred stock, 0.001 par value, 50,000,000 shares authorized at september 30, 2023 and december 31, 2022; no shares issued and outstanding at september 30, 2023 and december 31, 2022
                          
      trade accounts receivable, net of allowances of 508 and 445 at june 30, 2023 and december 31, 2022, respectively
             100,184,000             
      deferred revenues
             290,663,000 278,407,000 278,038,000 271,721,000 249,374,000 234,389,000 223,031,000 211,029,000 180,707,000 167,868,000 160,443,000 151,532,000 130,309,000 
      deferred revenues, non-current
             64,388,000 62,435,000 68,112,000 69,509,000 67,578,000 58,110,000 59,097,000 59,338,000 57,750,000     
      preferred stock, 0.001 par value, 50,000,000 shares authorized at june 30, 2023 and december 31, 2022; no shares issued and outstanding at june 30, 2023 and december 31, 2022
                          
      trade accounts receivable, net of allowances of 427 and 445 at march 31, 2023 and december 31, 2022, respectively
              84,392,000            
      preferred stock, 0.001 par value, 50,000,000 shares authorized at march 31, 2023 and december 31, 2022; no shares issued and outstanding at march 31, 2023 and december 31, 2022
                          
      trade accounts receivable, net of allowances of 445 and 391 at december 31, 2022 and 2021, respectively
               88,163,000           
      preferred stock, 0.001 par value, 50,000,000 shares authorized at december 31, 2022 and 2021; no shares issued and outstanding at december 31, 2022 and 2021
                          
      trade accounts receivable, net of allowances of 462 and 391 at september 30, 2022 and december 31, 2021, respectively
                92,882,000          
      preferred stock, 0.001 par value, 50,000,000 shares authorized at september 30, 2022 and december 31, 2021; no shares issued and outstanding at september 30, 2022 and december 31, 2021
                          
      trade accounts receivable, net of allowances of 479 and 391 at june 30, 2022 and december 31, 2021, respectively
                 96,450,000         
      preferred stock, 0.001 par value, 50,000,000 shares authorized at june 30, 2022 and december 31, 2021; no shares issued and outstanding at june 30, 2022 and december 31, 2021
                          
      trade accounts receivable, net of allowances of 492 and 391 at march 31, 2022 and december 31, 2021, respectively
                  81,121,000        
      preferred stock, 0.001 par value, 50,000,000 shares authorized at march 31, 2022 and december 31, 2021; no shares issued and outstanding at march 31, 2022 and december 31, 2021
                          
      trade accounts receivable, net of allowances of 391 and 530 at december 31, 2021 and 2020, respectively
                   79,143,000       
      preferred stock, 0.001 par value, 50,000,000 shares authorized at december 31, 2021 and 2020; no shares issued and outstanding at december 31, 2021 and 2020
                          
      trade accounts receivable, net of allowances of 460 and 530 at september 30, 2021 and december 31, 2020, respectively
                    69,486,000      
      preferred stock, 0.001 par value, 50,000,000 shares authorized at september 30, 2021 and december 31, 2020; no shares issued and outstanding at september 30, 2021 and december 31, 2020
                          
      trade accounts receivable, net of allowances of 480 and 530 at june 30, 2021 and december 31, 2020, respectively
                     66,667,000     
      preferred stock, 0.001 par value, 50,000,000 shares authorized at june 30, 2021 and december 31, 2020; no shares issued and outstanding at june 30, 2021 and december 31, 2020
                          
      ​
                          
      trade accounts receivable, net of allowances of 603 and 530 at march 31, 2021 and december 31, 2020, respectively
                      75,882,000    
      deferred revenues, noncurrent
                      53,711,000 45,507,000 36,706,000 27,429,000 
      preferred stock, 0.001 par value, 50,000,000 shares authorized at march 31, 2021 and december 31, 2020; no shares issued and outstanding at march 31, 2021 and december 31, 2020
                          
      trade accounts receivable, net of allowances of 530 and 200 at december 31, 2020 and 2019, respectively
                       69,056,000   
      debt
                         201,891,000 
      preferred stock, 0.001 par value, 50,000,000 and no shares authorized at december 31, 2020 and 2019, respectively; no shares issued and outstanding at december 31, 2020 and 2019
                          
      trade accounts receivable, net of allowances of 513 and 200 at september 30, 2020 and december 31, 2019, respectively
                        64,151,000  
      preferred stock, 0.001 par value, 50,000,000 and no shares authorized at september 30, 2020 and december 31, 2019, respectively; no shares issued and outstanding at september 30, 2020 and december 31, 2019
                          
      trade accounts receivable
                         53,275,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.